Retrieve available abstracts of 11 articles: HTML format
Single Articles
January 2025
SIDAWAY P Women with clinically node negative breast cancer can safely avoid axillary
surgery.
Nat Rev Clin Oncol. 2025 Jan 3. doi: 10.1038/s41571-024-00982. PubMed
November 2024
KILLOCK D First-line triplet therapy for advanced-stage PIK3CA-mutant HR(+) breast cancer
improves outcomes.
Nat Rev Clin Oncol. 2024 Nov 12. doi: 10.1038/s41571-024-00968. PubMed
DRAGO J, Modi S Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we
now?
Nat Rev Clin Oncol. 2024 Nov 6. doi: 10.1038/s41571-024-00963. PubMed
WAKS AG, Martinez-Saez O, Tarantino P, Braso-Maristany F, et al Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance.
Nat Rev Clin Oncol. 2024;21:818-832. PubMedAbstract available
August 2024
LLOYD MR, Jhaveri K, Kalinsky K, Bardia A, et al Precision therapeutics and emerging strategies for HR-positive metastatic breast
cancer.
Nat Rev Clin Oncol. 2024 Aug 23. doi: 10.1038/s41571-024-00935. PubMedAbstract available
MARRA A, Chandarlapaty S, Modi S Author Correction: Management of patients with advanced-stage HER2-positive
breast cancer: current evidence and future perspectives.
Nat Rev Clin Oncol. 2024 Aug 2. doi: 10.1038/s41571-024-00933. PubMed
July 2024
YOON J, Oh DY HER2-targeted therapies beyond breast cancer - an update.
Nat Rev Clin Oncol. 2024 Jul 22. doi: 10.1038/s41571-024-00924. PubMedAbstract available
June 2024
KILLOCK D ALND can be safely omitted for patients with sentinel-node macrometastases.
Nat Rev Clin Oncol. 2024;21:402. PubMed
May 2024
DIECI MV, Guarneri V Gaining ground in personalized breast cancer therapy: lesson learned from
PHERGain.
Nat Rev Clin Oncol. 2024 May 22. doi: 10.1038/s41571-024-00907. PubMed
April 2024
SIDAWAY P KN046 shows tolerability and activity in TNBC.
Nat Rev Clin Oncol. 2024;21:251. PubMed
March 2024
KONTOS D The promise of AI in personalized breast cancer screening: are we there yet?
Nat Rev Clin Oncol. 2024 Mar 12. doi: 10.1038/s41571-024-00877. PubMed